Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
暂无分享，去创建一个
S. Rosenkranz | P. Corris | H. Ghofrani | R. Benza | G. Simonneau | M. Hoeper | C. Vizza | V. McLaughlin | E. Grünig | Sung‐A Chang | D. Langleben | F. Kleinjung | A. Vonk-Noordegraaf | T. Pulido | R. White | J. Klinger | J. Gibbs | A. Peacock | P. Jansa | C. Meier | J. Ota-Arakaki | G. Meyer | H. Al-hiti | K. Paraschin | Mikyung Chang